Drug intelligence / Profile preview

menthoxypropanediol

Development stage: Unknown
Modality: Small Molecules
Administration: Topical

Overview

Menthoxypropanediol is a synthetic derivative of menthol known for its strong cooling properties. It is used in various cosmetic, oral care, and pharmaceutical products to provide a refreshing sensation and mask odors. It acts as a TRPM8 agonist, which helps in relieving itching, especially in conditions like atopic dermatitis[1][2][4][16].

Brand names: Coolact 10Coolact10Coolact-10
Other names: 3-[(l)-Menthoxy]propane-1,2-diolMOPDFEMA 3784FEMA3784FEMA-37843-L-MENTHOXYPROPANE-1,2-DIOL3-1-MENTHOXYPROPANE-1,2-DIOL3-[[5-Methyl-2-(1-methylethyl)cyclohexyl]oxy]-1,2-propanediol1,2-Propanediol, 3-[[5-methyl-2-(1-methylethyl)cyclohexyl]oxy]-

Targets

TRPM8 (Transient receptor potential cation channel subfamily M member 8)

Beyond the preview

Go deeper on menthoxypropanediol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on menthoxypropanediol.

Explore the full profile